Drug-Resistant Infections Surge Across European Hospitals
European hospitals report a 72% surge in drug-resistant Klebsiella pneumoniae infections, missing 2030 health targets and highlighting the limitations of…

European healthcare systems are facing a significant increase in antimicrobial resistance, characterized by a 72% rise in bloodstream infections caused by drug-resistant Klebsiella pneumoniae between 2019 and 2025. This trend significantly exceeds established public health targets, which aimed for a 5% reduction in these infections by 2030. Mortality rates for these specific infections range between 40% and 70%, presenting a critical challenge to hospital safety and patient outcomes.
Data indicates that several strains of the bacterium have developed resistance to nearly all available antibiotics, including newly developed treatments. While infection control measures have successfully reduced rates of MRSA by 19% since 2019, these protocols have proven insufficient against Klebsiella pneumoniae. Experts attribute this to the bacterium's ability to persist in human reservoirs, necessitating more rigorous hygiene and environmental disinfection standards than those currently applied in many clinical settings.
Furthermore
Broader antimicrobial resistance trends remain concerning, with E. coli infections increasing by 16.4% over the same period, missing the 10% reduction target. Furthermore, total antibiotic consumption in the EU declined by only 5%, falling well short of the 20% reduction goal set for 2030. While the proportion of appropriate antibiotic usage has reached 62.5%, the overall pace of improvement remains behind schedule.
Legislative efforts are underway to address these systemic risks, with new pharmaceutical regulations expected in December. These measures aim to incentivize the development of new antibiotics through market exclusivity and structured procurement models. Health authorities are increasingly prioritizing genomic surveillance to improve the speed of transmission detection and to better inform clinical treatment decisions in high-risk hospital environments.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- Europe faces 35,000 drug-resistance deaths a year
- U.S. faces loss of measles elimination status after 5,412 cases
Latest news
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike
- Europe faces attribution gap after 16 cyber, physical incidents

